Viemed Healthcare Announces First Quarter 2026 Financial Results

May 5, 2026 5:00 PM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026.Operational highlights (all dollar amounts are USD):Net revenues for the quarter ended March 31, 2026 were...

Read more

Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 5, 2026 4:05 PM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the first quarter ended March 31, 2026, and provided a corporate update."The first quarter of 2026 marked a series of landmark achievements for Protagonist, highlighted by the U.S. approval of ICOTYDE, FDA granting Priority Review for rusfertide, and advancement of our highly differentiated and fully-owned peptides PN-881 and PN-477,"...

Read more

Omni-Biotic Ranked #1 Probiotic Brand in Europe, Reflecting Strong Consumer Trust and Scientific Foundation

May 5, 2026 12:10 PM

Omni-Biotic U.S. announced today that Omni-Biotic has been ranked the #1 probiotic brand in Europe, based on IQVIA Consumer Health Customized Insight Study data. This distinction reflects the brand's leading position across European markets and underscores its continued expansion in the United States.In an increasingly competitive probiotic category, Omni-Biotic's leadership is driven by strong consumer adoption, practitioner endorsement, and a...

Read more

MilliporeSigma Receives 2026 Environment+Energy Leader Spotlight Award

May 5, 2026 11:00 AM

The 2026 Environment+Energy Leader Awards have recognized MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, for its commitment to preparing scientists to address sustainability through chemistry.The company received a Spotlight Award in the Collaboration category for its partnership with Beyond Benign, a leading green chemistry education non-profit devoted to empowering educators to transform chemistry...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Advances AI Platform Accuracy for Early Melanoma Detection

May 5, 2026 10:15 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), an emerging developer of AI-powered health and wellness technologies, today announced that it is actively evaluating and integrating new advances in artificial intelligence to support the development of high accuracy dermatological imaging solutions focused on early-stage skin condition detection. Building upon its patent-pending imaging platform, the Company is...

Read more

Utah Medical Products, Inc. Announces Quarterly Dividend

May 5, 2026 10:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies,...

Read more

RADIESSE(R) Receives FDA Approval for Décolleté Wrinkles as Dr. Rubinstein Provides Proven, FDA-Approved Solutions in New York and New Jersey

May 5, 2026 8:00 AM

Merz Aesthetics has announced that the FDA has approved RADIESSE® for the treatment of wrinkles in the décolleté area in patients 22 years of age or older - making it the first and only biostimulator in the United States approved for both the face and the body. This marks the fourth FDA-approved indication for RADIESSE, further cementing its position as one of the most versatile and clinically supported injectable treatments available in...

Read more

MEDIA ADVISORY: Grand Opening and Community Blood Drive Address Critical Local Need

May 5, 2026 8:00 AM

Advanced Health will host a community open house and blood drive on May 19, 2026, celebrating the opening of its new primary care office and reinforcing its commitment to improving access to high-quality, patient-centered care for the Greenville community.EVENT DETAILSWhat: Grand Opening + Community Blood DriveWhen: May 19, 2026 | 4 - 6 pmWhere: 56 Pointe Circle, Suite 200 Greenville SC 29615Who: Open to the public; media invited Offering...

Read more

AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line

May 5, 2026 8:00 AM

AMC Health today announced the appointment of Sol Babani, Founder and CEO of Symbiosis Advisors, as Strategic Advisor to its newly established Decentralized Clinical Trial (DCT) service line. Babani will work closely with CEO Nesim Bildirici and Keith Tode, Executive Vice President of Decentralized Clinical Trials, to grow and operationalize AMC Health's DCT platform as it expands its modular operating partner offering to biopharmaceutical...

Read more

CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Pouches Nicotine Free

May 5, 2026 7:00 AM

CBD Life Sciences Inc. (OTCID:CBDL) CBD Life Sciences Inc. is proud to announce our latest product CBD Pouches that are Nicotine Free. Our Tins Pouches are made for anyone looking for an easy, hassle-free way to enjoy the benefits without overcomplicating things. They offer a familiar chew-style experience with an added sense of relaxation-ideal for unwinding or making it through your day with less stress. Crafted from natural ingredients, these...

Read more

Europe Rejects Hemp, Marijuana CBD Safety - As U.S. Court Weighs Halting Medicare CMS Program Exposing Seniors To Unproven Products

May 5, 2026 6:00 AM

A federal judge is now deciding whether to halt a controversial Medicare linked hemp, marijuana CBD program-just as Europe's top scientific authority has delivered a stunning conclusion:It cannot confirm that a leading CBD product is safe for human consumption. The finding, issued by the European Food Safety Authority (EFSA)-widely regarded as the European equivalent of the U.S. Food and Drug Administration directly challenges the scientific...

Read more

TherapyHive Featured in The New York Times for Its Innovative Therapist Office Rental Model

May 5, 2026 6:00 AM

TherapyHive, a flexible workspace and professional community for mental health professionals, has been featured in The New York Times for its innovative solution to the rising cost of therapy office space and the changing landscape of mental health care.The feature appeared in a New York Times business article examining how doctors and therapists are adapting to climbing commercial rents by finding creative ways to share or sublease office...

Read more

AlzeCure Publishes its Interim Report for January – March 2026

May 5, 2026 2:20 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6) today announced that its interim report for the period January - March 2026 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/"During the first quarter of 2026, our focus was on preparing the Phase II study in Alzheimer's patients with NeuroRestore ACD856, for which we were awarded a grant of EUR 2.5 million from the European Innovation Council...

Read more

Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders

May 4, 2026 5:55 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce the voting results from its annual general and special meeting (the "Meeting") of the shareholders of the Company (the "Shareholders") held on May 4, 2026.A total of 4,135,344 common shares were represented in person or by proxy at the Meeting, representing 27.85% of the total issued and outstanding common shares of the Company.The complete...

Read more

Medical Component Specialists to Support Advanced Catheter Innovation at The Catheter R&D Masterclass in Ireland

May 4, 2026 3:30 PM

Medical Component Specialists (MCS), a premier manufacturer of precision medical components, today announced its participation as a supporting organization at The Catheter R&D Masterclass. Hosted by Eyedea Medtech, the highly anticipated event will take place May 28-29, 2026, at the Prototyping and Education Facility in Westport, Mayo, Ireland. The Catheter Systems Lab is an exclusive, dual-purpose educational program designed for senior...

Read more

Pharmacists Mutual Advances Strategic Growth Initiative Through Collaboration with Positive Physicians

May 4, 2026 2:55 PM

Pharmacists Mutual Insurance Group ("Pharmacists Mutual") today announced a strategic collaboration with Positive Physicians Insurance Company ("Positive Physicians"), further advancing the Company's long-term growth strategy within the healthcare professional liability market.This collaboration represents a deliberate step in expanding Pharmacists Mutual's professional liability capabilities through alignment with a highly focused and...

Read more

Philip Ashton-Rickardt Calls for Greater Focus on Innovation in Neurodegenerative Disease Treatment

May 4, 2026 2:50 PM

Philip Ashton-Rickardt, Managing Director and Chief Scientific Officer at BE Therapeutics, is speaking out about the urgent need for stronger awareness, sustained effort, and innovation in the fight against neurodegenerative diseases such as ALS and multiple sclerosis.With decades of experience across academia and biotech, Ashton-Rickardt is calling on scientists, entrepreneurs, and individuals alike to take a more active role in supporting...

Read more

Alliant Health Solutions Awarded Multiple CMS ESRD Network Contracts, Expanding Impact Across Eight States

May 4, 2026 11:15 AM

Alliant Health Solutions (AHS) announced it has been awarded new End Stage Renal Disease (ESRD) Network contracts by the Centers for Medicare & Medicaid Services (CMS) for Networks 7, 8, 13, and 14. This significant achievement expands Alliant's footprint across eight states: Florida, Alabama, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. These awards build on Alliant's established leadership in ESRD Networks 8 and 14,...

Read more

Encision Inc. Announces Halt of Stock Trading

May 4, 2026 10:25 AM

Encision Inc. (OTC Pink:ECIA), a medical device company that owns patented Active Electrode Monitoring (AEM®) technology designed to prevent dangerous stray energy burns in minimally invasive surgery, today announced that trading in its common stock has been halted. The halt in trading results from the Company's filing of a Form 15 with the Securities and Exchange Commission ("SEC") to voluntarily deregister its common stock under Section 12(g)...

Read more

Bulletin from the Annual General Meeting in Ascelia Pharma AB on 4 May 2026

May 4, 2026 10:10 AM

Ascelia Pharma (STO:ACE) - Today, on 4 May 2026, an annual general meeting was held in Ascelia Pharma AB. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes, except as set out below.Resolution on adoption of accounts and allocation of the company's resultThe annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement...

Read more